Medicine and Health
Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
N. Islam, N. E. Sheils, et al.
This study, conducted by Nazmul Islam, Natalie E. Sheils, Megan S. Jarvis, and Kenneth Cohen, reveals that the mRNA-1273 (Moderna) vaccine offers slightly more protection against SARS-CoV-2 infection compared to the BNT162b2 (Pfizer-BioNTech) vaccine, particularly at 90 days post-vaccination, although both vaccines show similar protection against severe outcomes. Dive into the findings of over 3.5 million fully vaccinated individuals!
Related Publications
Explore these studies to deepen your understanding of the subject.

